Praxair Reports Full-Year and Fourth-Quarter 2015 Results

KeyBanc Downgrades Praxair Inc. (PX) to Sector Weight

KeyBanc downgraded Praxair Inc. (NYSE: PX) from Overweight to Sector Weight and removed its price target. The change follows the release of Q4 results.

Analyst Michael J. Sison said, "We are downgrading PX to Sector Weight from OW given another significant cut to... More

Jefferies Cuts Price Target on Praxair (PX) As FX Headwinds Effect EPS

Jefferies maintained a Buy rating on Praxair Inc. (NYSE: PX), and cut the price target to $115.00 (from $126.00), following the company's 4Q earnings report. Jefferies believes that, with FX headwinds pushing EPS towards 2011 levels, PX's 2016 performance hindges on new project announcements.

Analyst Laurence... More

UPDATE: UBS Upgrades Praxair Inc. (PX) to Buy

(Updated - February 1, 2016 8:13 AM EST)

UBS upgraded Praxair Inc. (NYSE: PX) from Neutral to Buy with a price target of $109.00.

Analyst John Roberts commented, "We see PX as one of the most defensive stocks in the chemicals space. The stock is... More

Praxair (PX) Raises Quarterly Dividend 4.9% to $0.75; 3.1% Yield

Praxair (NYSE: PX) declared a quarterly dividend of $0.75 per share, or $3 annualized. This is a 4.9% increase from the prior dividend of $0.715.

The dividend will be payable on March 15, 2016, to stockholders of record on March 7, 2016, with an ex-dividend date of March 3,... More

Praxair (PX) Reports In-Line Q4 EPS

Praxair (NYSE: PX) reported Q4 EPS of $1.47, in-line with the analyst estimate of $1.47. Revenue for the quarter came in at $2.6 billion versus the consensus estimate of $2.66 billion.

GUIDANCE:

Praxair sees FY2016 EPS of $5.30-$5.70, versus the consensus of $3.06.

For earnings history and earnings-related data on Praxair (PX) click here.